Scientific Program - Retina

Please see below the COPHy Scientific Program. Please click on the appropriate section to view the relevant program. Please note that the program is subject to change. To view the program timetable / overview, please click here

Anterior Segment Glaucoma Other
FRIDAY, MARCH 23, 2018
OPENING SESSION | Big Controversies in Ophthalmology in 2018
Chairs: Neil Bressler, USA and Sobha Sivasprasad, UK
09:00-09:30 Debate I: Proliferative Diabetic Retinopathy: Anti VEGF without PRP is an Acceptable First Step
09:00-09:10 Yes: Sobha Sivaprasad, UK
09:10-09:20 No: Bora Eldem, Turkey
09:20-09:30 Discussion
09:30-10:00 Debate II: Wide-field imaging typically should be obtained in diabetic retinopathy
09:30-09:40 Yes: James Talks, UK
09:40-09:50 No: Alexander Charonis, Greece
09:50-10:00 Discussion
10:00-10:30 Debate III: Neuro-protection in Glaucoma: A Viable Pursuit
10:00-10:10 Yes: Francesca Cordeiro, UK
10:10-10:20 No: Neil Miller, USA
10:20-10:30 Discussion
10:30-11:00 Visit Exhibits & Coffee and Refreshment Break
RETINA I | Neovascular (‘Wet”) AMD Management
Chairs: Francesco Bandello, Italy and Miltiadis Tsilimbaris, Greece
11:00-11:30 Debate I: Brolucizumab represents an incremental improvement over aflibercept
11:00-11:10 Yes: Francesco Bandello, Italy
11:10-11:20 No: Miltiadis Tsilimbaris, Greece
11:20-11:30 Discussion
11:30-12:00 Debate II: Atrophy post anti-VEGF is likely caused by a toxic effect of anti-VEGF
11:30-11:40 Yes: Tryfon Rostos, Greece
11:40-11:50 No
11:50-12:00 Discussion
12:00-12:30 Debate III: Bevacizumab gives similar outcomes as other anti-VEGF agents using "PRN” or "Treat and Extend” regimens
12:00-12:10 Yes: Michaella Goldstein, Israel
12:10-12:20 No: Susan Bressler, USA
12:20-12:30 Discussion
12:30-12:45 Visit Exhibits & Technical Break
INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) (Lunch box served in hall 12:45-13:00)
14:00-14:30 Visit Exhibits & Dessert Break
RETINA II | Imaging Controversies
Chairs: Susan Bressler, USA and Sofia Androudi, Greece
14:30-15:00 Debate I: Fluorescein angiography can detect VEGF activity not noted on OCT that warrants retreatment in AMD
14:30-14:40 Yes: Susan Bressler, USA
14:40-14:50 No: Paolo Lanzetta, Italy
14:50-15:00 Discussion
15:00-15:30 Debate II: Access to OCT-A can improve outcomes in age-related macular degeneration
15:00-15:10 Yes: Francesco Bandello, Italy
15:10-15:20 No: Sofia Androudi, Greece
15:20-15:30 Discussion
15:30-16:00 Debate III: Autofluorescence imaging should be used to monitor geographic atrophy
Yes: Sobha Sivaprasad, UK
15:40-15:50 No
15:50-16:00 Discussion


Saturday March 24, 2018
08:00-09:00 Breakfast Session | Hot Controversies in Ophthalmology: A Vision Academy Perspective
Chairs: Neil Bressler, USA and Ian Pearce, UK
08:00-08:10 An introduction to the Vision Academy: Neil Bressler, USA and Ian Pearce, UK
08:10-08:30 Debate I: Treatment with Anti-VEGF agents in AMD should be stopped when benefits to the patient no longer can be expected
08:10-08:15 For: Anat Loewenstein, Israel
08:15-08:20 Against: Tien Yin Wong, Singapore
08:20-08:25 Presentation of viewpoint: Tien Yin Wong, Singapore
08:25-08:30 Questions
08:30-08:50 Debate II: Optimal treatment regimen with anti-VEGF in AMD
08:30-08:35 PRN: James Talks,UK
08:35-08:40 Treat and extend: Paulo Lanzetta, Italy
08:40-08:45 Presentation of viewpoint: Paolo Lanzetta, Italy
08:45-08:50 Questions
08:50-09:00 Looking forward with the Vision Academy: Anat Loewenstein, Israel and Ian Pearce, UK
09:00-10:30 RETINA III | Diabetic Macular Edema (DME)
Chairs: Michaella Goldstein, Israel and Efstratios Paroikakis, Greece
09:00-09:30 Debate I: Current initial management of non-central DME should be laser
09:00-09:10 Yes: Ian Pearce, UK
09:10-09:20 No: Paolo Lanzetta, Italy
09:20-09:30 Discussion
09:30-10:00 Debate II: Access to OCT angiography can improve outcomes in diabetic macular edema
09:30-09:40 Yes: Tien Yin Wong, Singapore
09:40-09:50 No: Bora Eldem, Turkey
09:50-10:00 Discussion
10:00-10:30 Debate III: Baseline OCT features predict visual acuity outcomes independent of baseline visual acuity in diabetic macular edema
10:00-10:10 Yes: Irini Chatziralli, Greece
10:10-10:20 No: Susan Bressler, USA
10:20-10:30 Discussion
10:30-11:00 Visit Exhibits & Coffee and Refreshment Break
RETINA IV | Surgical Retina and Trauma
Chairs: William F. Mieler, USA and Joseph Moisseiev, Israel
11:00-11:22 Debate I: Vitreo-macular traction typically should be managed by vitrectomy rather than pneumatic vitreolysis or ocriplasmin
11:00-11:08 Yes: Panagiotis Theodossiadis, Greece
11:08-11:16 No: William Mieler, USA
11:16-11:22 Discussion
11:22-11:44 Debate II: Total retinal detachment with 1 hour equatorial tear at 5 o'clock, phakic eye, 40 years old: vitrectomy, not scleral buckle
11:22-11:30 Yes: Petros Petrou, Greece
11:30-11:38 No: Joseph Moisseiev, Israel
11:38-11:44 Discussion
11:44-12:06 Debate III: Routinely remove ILM with ERM removal
11:44-11:52 Yes: Stratos Gotzaridis, Greece
11:52-12:00 No: William Mieler, USA
12:00-12:06 Discussion
12:06-12:30 Debate IV: Prompt vitrectomy for 3-day old vitreous hemorrhage in an eye without previous symptoms
12:06-12:14 Yes: Francesco Boscia, Italy
12:14-12:22 No: Chrysanthi Koutsandrea, Greece
12:22-12:30 Discussion
12:30-12:45 Visit Exhibits & Lunch Box Pick-Up
INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME) (Lunch box served in hall 12:45-13:00)
14:00-14:30 Visit Exhibits & Dessert Break
RETINA V | Non-neovascular ("Dry") Age-related Macular Degeneration
Chairs: Susan Bressler, USA and Michaella Goldstein, Israel
14:30-14:50 Debate I: Complement inhibition remains a promising strategy for geographic atrophy
14:30-14:37 Yes: Jordi Monés, Spain
14:37-14:44 No: Miltiadis Tsilimbaris, Greece
14:44-15:50 Discussion
14:50-15:10 Debate II: Cataract surgery in eyes with non-neovascular AMD increases risk of conversion to choroidal neovascular AMD
14:50-14:57 Yes: Efstratios Paroikakis, Greece
14:57-15:04 No: Michaella Goldstein, Israel
15:04-15:10 Discussion
15:10-15:30 Debate III: Amsler grid should be used for home monitoring
15:10-15:17 Yes: Sobha Sivaprasad, UK
15:17-15:24 No: Susan Bressler, USA
15:24-15:30 Discussion